Treating symptoms before they gain momentum; 50,000 patients needed for clinical trials
$8.75M award will help probe links with immune-related neuroinflammation
Shared medical appointments offer added resources
Possible surrogate biomarker for AD subtype, retrospective study suggests
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A brain health expert looks ahead to phase 3 testing
'Weight may accelerate aging of brain’ studies show
How recent failures may bring disease-modifying success a bit closer
Phase 3 study of aducanumab enrolling in Las Vegas, Ohio, Florida
Citalopram and dextromethorphan-quinidine show promise in trials